Showing posts with label FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%. Show all posts
Showing posts with label FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%. Show all posts
Monday, January 9, 2017

Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%

›
Allergan plc  announced that the New Drug Application (NDA) filing for oxymetazoline HCl cream 1.0%, an investigational topical prescript...